RTA 408 Ophthalmic Suspension for the Treatment of Ocular Inflammation and Pain Following Ocular Surgery
Status:
Completed
Trial end date:
2014-09-01
Target enrollment:
Participant gender:
Summary
This study assesses the efficacy and safety of two concentrations of RTA 408 Ophthalmic
Suspension in the treatment of patients who have inflammation and pain following ocular
surgery.